Introduction
The essential condition for understanding the function of the immune system is to know as completely as possible its components, their properties, functions and mutual relations on a molecular level. That is, the first necessary step is to do a basic 'inventory' of all parts of the system. One of the most active areas in this respect is the investigation of surface macromolecules of leucocytes. Many leucocyte surface components have been identified, mostly with the aid of monoclonal antibodies, including such important molecules as various receptors and cell adhesion molecules. The final goal of these efforts is to identify and functionally define all surface components of all types of leucocytes. It is not clear how close to this ideal we are now, but it seems likely that many, perhaps most, of the leucocyte membrane proteins and glycoproteins are yet to be discovered.
In the present review we attempt to summarize the information available on the surface components of human leucocytes identified so far.
Because of space limitations and enormous extent of the field to be covered, we had to restrict the discussion only to the structurally and functionally best known and most interesting molecules. Also, we had to keep the number of citations to a minimum of those most recent and most relevant and wherever possible we cite detailed reviews on individual molecules. We apologize to the authors of all papers not cited for this reason. The Tables attached contain basic information on most human leucocyte surface antigens* for which at least a minimum of biochemical data (Mr) is available. For the sake of clarity, we grouped all these antigens in Tables according to their prevalent expression on different cell types [i.e. antigens of T lymphocytes, B lymphocytes, NK (natural killer) cells, myeloid cells (monocytes, macrophages and granulocytes) and finally antigens with broader expression]. We are aware that our classification is sometimes rather arbitrary, but, strictly speaking, there are very few molecules expressed absolutely specifically on a certain leucocyte subpopulation and most antigens should be in fact classified as 'lineage non-specific'. In this review we use as much as possible the 'CD nomenclature' of the International Workshops on Human Leucocyte Differentiation Antigens (Bernard et al., 1984a; Reinherz et al., 1986; McMichael et al., 1987) , which greatly clarifies certain confusion due to using different arbitrary names by different authors for identical molecules.
Thus, in the text we concentrate more on functional aspects, relations between various membrane molecules etc., while descriptive facts on Mr values, expression and nomenclature can be found mostly in the Tables.
Antigen-specific receptors and functionally related molecules Recognition of substances foreign to an organism is the basis of immune response. The recognition is accomplished by soluble recognition molecules, i.e. immunoglobulins, and by membrane-bound antigenspecific receptors. There are basically two kinds of these receptors: membrane immunoglobulins of B lymphocytes and so called T cell antigen receptors of T lymphocytes. These are some similarities but also important differences between these two systems.
Membrane-bound immunoglobulins are structurally very similar to the secreted soluble immunoglobulins, except for a C-terminal hydrophobic stretch of amino acids in the heavy chain which serves to anchor the molecule in the lipid membrane of B lymphocytes (Rogers et al., 1980) . The membrane-bound immunoglobulins are mostly of IgM and IgD isotype; essentially nothing is known about possible functional differences between these isotypes but apparently both murine mIgM and mIgD (as well as mIgG) can act as signal transmission molecules (Mizuguchi et al., 1986) . Structure, mechanisms of generation of binding sites diversity and molecular genetics of immunoglobulins have been subjects of numerous reviews and therefore need not be discussed here. Each B lymphocyte clone carries mlgs of unique structure of combining site and thus exhibits unique antigen specificity. Recognition of the respective antigen by this surface receptor provides a signal necessary for activation of the B lymphocyte, its clonal expansion and terminal differentiation into either memory B cells or plasma cells, which secrete soluble immunoglobulin of structure and specificity identical with or very similar to that of the mlg on the originally stimulated B lymphocyte (somatic mutations during this proliferation/differentiation process can alter affinity and fine specificity of the resulting immunoglobulins). The biochemical basis of transmembrane signalling through mIg was thoroughly reviewed by Cambier et al. (1987a) ; it involves the second messenger system based on hydrolysis of phosphatidylinositol bisphosphate, rise of intracytoplasmic Ca2l concentration and activation of protein kinase C. In most cases further 'helper' signals are necessary in addition to the primary signal provided by the antigen-mIg interaction to achieve proliferation and terminal differentiation of the B lymphocytes. These secondary signals are provided by lymphokines secreted mostly by helper T lymphocytes. Which of these second signals are necessary and sufficient under physiological conditions (and in which order) is not exactly known, but in vitro interleukins 1, 2, 4, 5 and 6, and IgE, C3d and probably also other factors, were shown to enhance B Vol. 253
Abbreviations used: BCGF, B cell growth factor; EGF, epidermal growth factor; GM-CSF, granulocyte-monocyte colony stimulating factor; mlg, membrane immunoglobulin; mAb, monoclonal antibody; MHC, major histocompatibility complex; NK, natural killer; Tc, cytotoxic T-cell; Th, helper T cell; T., suppressor T cell; Workshop, International Workshop on Human Leucocyte Differentiation Antigens. * We will frequently use a convenient although imprecise term 'antigen', meaning here actually a 'protein or glycoprotein'. The use of this term is justified as practically all molecules described here have been identified by means of antibodies.
cell stimulation (for review see, e.g., Jelinek & Lipsky, 1987) .
At least some of the complexes of mIg with the antigen recognized are internalized and the (protein) antigen is then cleaved into peptide fragments. Some of these peptides associate specifically with MHC class II glycoproteins (see below) and these complexes are then re-expressed at the cell surface where they can be recognized by specific helper T cell clones through their T cell receptors (Lanzavecchia, 1985) . This interaction initiates activation and proliferation of these specific Th cells which in turn produce the above mentioned helper factors to the B lymphocytes. Thus, mlg serves also to concentrate the antigen on specific B lymphocyte surfaces and transport it inside the cell where it is 'processed' to yield fragments capable of interaction with MHC glycoproteins and recognizable then by Th. Although other cells, e.g. macrophages, are also efficient in processing antigens and presenting them to Th in association with MHC glycoproteins, specific B cells are now thought to be the major antigen processing and presenting cells for soluble protein antigens occurring typically only in minute concentrations.
Major unresolved questions concerning mlg are as follows. (1) What are in exact molecular terms the mechanisms of signal transduction through this receptor? It is not exactly known what molecule(s) associated with mlg may be the first signal-transducing element triggering the phosphatidylinositol bisphosphate/Ca2+/protein kinase C-mediated activation pathway. In this respect the 30 kDa molecule reported to be covalently linked to murine mIgM might be relevant (Haustein & van der Ahe, 1986) . (2) What is the functional relevance of isotypic differences (IgM, IgD) of mlg expressed on different B cells? It is also unclear what is the role of unusual forms of mlg observed in mouse B cells: in addition to the usual L2H2molecules, there are also LH 'half molecules', free heavy (H) chains and their dimers (Haustein & van der Ahe, 1986) .
The antigen-specific surface receptors of T lymphocytes are structurally related to immunoglobulins. The structure, function and molecular genetics of these receptors have been recently reviewed several times (e.g. Collins & Owen, 1985; Kronenberg et al., 1986; Marrack & Kappler, 1987 (Carrel et al., 1987) are so far rather indirect. True topological relations between different noncovalently associated components are unknown, except that the CD3-y chain seems to be in contact with the T cell receptor fi chain (Brenner et al., 1985 Bank et al., 1986) . Actually, at least two kinds of the human T cell receptor y chain exist (36-40 kDa and 55 kDa, respectively), differing in their constant domains and in glycosylation Littman et al., 1987) , as well as in the mode of their association with the-chain. The smaller form is disuiphide-linked to the chain, while the larger form is associated noncovalently to it. A form of T cell receptor consisting of two y chains may also exist (Koning et al., 1987) . The structure of T cell receptor a, , and y chains are all similar to each other; cDNA and the gene coding for the a chain were cloned recently and the predicted corresponding protein also has a similar sequence Band et al., 1987) . Both the a, and y6 T cell receptors are noncovalently associated with the so-called CD3 complex, consisting of CD3-y, CD3-6, CD3-e and a covalent dimer of CD3-chains (see Table 1 and Fig. 1 ). The association of the T cell receptor with CD3 is rather loose, but is preserved after solubilization in some detergents such as digitonin (Oettgen et al., 1984) . All CD3 chains are typical transmembrane proteins and have distant sequence similarities to the proteins of the immunoglobulin family (cf. Gold et al., 1987) [For an excellent review on this family of proteins and on the criteria justifying classification of a protein as a member of that family see Williams (1987) ]. The CD3 y chain is in close contact with the T cell receptor /3 chain in the native complex (Brenner et al., 1985) . The antigen-recognition structures are the T cell receptor clonotypic dimers, while the CD3 complex transmits probably the signal inside the cell. Essentially nothing is known about the specific roles of individual CD3 chains in this respect.
Biochemical events following antigen recognition by the T cell receptor were extensively studied employing monoclonal antibodies (mAbs) against CD3 or receptor. Binding of such mAbs under appropriate conditions (usually the mAbs have to be immobilized on a solid surface) is thought to mimick the physiological interaction with the antigen. Similarly, the well-known mitogenic effects of some lectins on T cells are also probably due to their interaction with the carbohydrate moieties of the receptor-CD3 complex. The cascade process initiated by interaction of receptor-CD3 with an antigen, mAb or lectin involves rapid hydrolysis of phosphatidylinositol bisphosphate, rise of intracellular Ca2l concentration and activation of protein kinase C (reviewed by Weiss et al., 1986; Isakov et al., 1987 , Alcover et al., 1987 , i.e. a pathway similar to the signal transduction via mlg in B lymphocytes. The CD3 complex might be therefore linked to a G-protein, to a phosphodiesterase splitting the phosphatidylinositol bisphosphate and/or to a Ca2l channel.
It is still possible that the T cell receptor-CD3 complex is an even more complicated structure and that additional components may be associated to it at least transiently. One of them may be the CD4 or CD8 molecule (see below), another perhaps CD2 (see the following section) and yet another a recently identified 45 kDa component (Carrel et al., 1987a) . Precise definition of complete structure and functions of all components of the T cell receptor supramolecular complex will be certainly of basic importance for understanding of signal transmission in T cells.
In spite of structural and molecular genetic similarities between mlg and T cell receptor, there is a major difference between these two receptors: while mlg can recognize the antigens as such, T cell receptors recognize it mostly in so called 'MHC-restricted' fashion, i.e. the antigen must be partially denatured and/or proteolytically cleaved (for review see Allen, 1987) A most exciting, so far unresolved question concerning the phenomenon of MHC-restricted recognition by T cell receptors is how only the cells carrying receptors with specificity for processed foreign antigens are selected during ontogeny (reviewed by Goverman et al., 1986) . There are several conceptually quite different hypotheses attempting to explain this, but probably the correct one is that the developing thymocytes encounter in thymus many different processed self-antigens associated with MHC glycoproteins and this recognition somehow leads to abortion of such T cell clones, e.g. by a mechanism similar to that suggested by Reinherz (1985) . Only the T cell clones which have not met any complementary structure in thymus are then allowed to emigrate into the periphery and can recognize 'unfamiliar', i.e. mostly foreign, structures (Werdelin, 1987; Kourilsky et al., 1987) . This still does not explain why the antigen recognized must be associated with MHC glycoproteins. Perhaps this is because an effective recognition requires T cell receptor crosslinking by multiple interactions with the antigen displayed on a cell surface or because other additional interactions are needed to make the contact productive, or maybe because there is after all some indispensable interaction between the T cell receptor complex and the 'carrier' MHC molecule. It should be noted that at least some antigens can bind to the 4,-type T cell receptor without being complexed to MHC glycoproteins (Siliciano et al., 1985) , but it is not clear how general and physiologically relevant this phenomenon is. The T lymphocytes carrying the ,u#-type T cell receptor recognize their targets apparently without 'MHC restriction' Bank et al., 1986) . It is not clear at present what are the structures recognized by this type of T cell receptor which should be much less clonotypically variable than the 'conventional' a,/-type (Quertermous et.al., 1986; Band et al., 1987) .
A puzzling phenomenon is that a large portion of T lymphocytes apparently recognize allogeneic forms of MHC molecules. This is usually interpreted as recognition of 'altered self' MHC molecules, which may appear to T cells like self MHC glycoprotein complexed with a foreign antigen. In our opinion, a more plausible (but so far unproven) explanation is that this 'alloreactivity' of T cells represents in fact recognition of various fragments of self antigens associated to the allogeneic MHC molecule -i.e. complexes never seen by the T cells during their development and therefore recognized as foreign (Werdelin, 1987) .
The purpose of MHC restriction seems to be rather Fleischer et al. (1986b) Fleischer ( glycoproteins (B lymphocytes, macrophages, activated T lymphocytes) and regulate their activities. Clearly, MHC glycoproteins are molecules functionally very relevant to the T cell receptor. They are the most thoroughly studied membrane glycoproteins; their structure, function and molecular genetics have been reviewed many times (e.g. Lew et al., 1986; Harris & Gill, 1986; Korman et al., 1985; Solheim et al., 1986 (Quaranta et al., 1984) and whose role is at present uncertain. Both a and ,l chains are transmembrane glycoproteins, and all chains except DRa are polymorphic. All constituent chains of MHC molecules bear sequence similarities to immunoglobulins. The three-dimensional structure of the HLA-A2 molecule has been determined recently, providing for the first time detailed structural information on a human membraneassociated molecule (Bjorkman et al., 1987a,b) . It is almost certain now that the MHC molecules are generally 'receptors for processed antigens'. Although this has not been proven directly for MHC class I glycoproteins yet, a great deal of indirect evidence (e.g. Gotch et al., 1987) as well as the three-dimensional structural data strongly suggest that these molecules do bind processed antigens. Direct binding experiments performed with mouse MHC class II glycoproteins repeatedly demonstrated that these molecules are capable ofbinding certain types ofpeptides, presumably those assuming a conformation of amphipathic ac-helix (e.g. Buus et al., 1987; Guillet et al., 1987; Unanue & Allen, 1987; Margalit et al., 1987) . It seems quite likely that a peptide-binding site of similar character to that found in the three-dimensional structure of the HLA-A2 molecule also exists in the MHC class II molecules (Bjorkman et al., 1987b) . In spite of enormous progress in the understanding of structure and function of MHC glycoproteins and the T cell receptor, a number of important issues remain still unclear, and these are discussed below.
Why do some T cells (mainly Tj) recognize antigens mostly in association with MHC class I glycoproteins, while others (mostly Th) in association with MHC class II molecules, although both these T cell subpopulations use the same kind of a,f T cell receptor? A possible explanation of this puzzle is that 'accessory molecules', namely CD4 and CD8 (Table 1) , mediate this MHC-typespecific interaction. There is a high correlation between CD4/CD8 expression and MHC class 11/class I restricted T cell recognition (Swain, 1983) . Moreover, anti-CD4 or anti-CD8 mAbs inhibit activation of the respective T cells induced by recognition of the antigen-presenting cell. CD4 may be physically associated with the T cell receptor complex (Saizawa et al., 1987) and therefore it may really constitute a component of the supramolecular complex recognizing a conserved part of MHC class II molecules; CD8 may be similarly associated with the T cell receptor (Takada & Engleman, 1987) and specifically recognize the MHC class I molecules. Although direct measurements of the MHC glycoprotein-CD4/CD8 interactions have not been performed so far, several lines of evidence strongly suggest that such interactions do exist (Aparicio et al., 1987; Doyle & Strominger, 1987) . The direct binding experiments should become feasible after production of soluble recombinant forms of CD4, CD8 and MHC glycoproteins. In addition to the possible MHC class II receptor function, CD4 appears to be linked to an antigen-activated Ca2" channel (Rosoffet al., 1987) which may be another reason why some anti-CD4 mAbs block activation of T cells. Importantly, CD4 is also the receptor for human immunodeficiency virus (HIV) (Dalgleish et al., 1984; McDougal et al., 1986) and it may also be a receptor for peptide mediators of monocyte chemotaxis (Ruff et al., 1987) . Structure and function of CD4 and CD8 (both these molecules belonging to the Ig family) have been reviewed (Dalgleish, 1986; Parnes, 1986 (Wernet et al., 1987) and possibly related to the molecule described by Carra & Accolla (1987) is presumably also involved in antigen presentation to Ts.
An important question is whether the peptide-binding ability is unique to MHC glycoproteins. A recent surprising finding indicates that a cell surface protein (72 and 74 kDa) exists that does bind peptides and presents them to T lymphocytes in an MHC-like manner (Lakey et al., 1987 ).
Yet another incompletely resolved problem is what is the meaning of the extreme polymorphism of MHC glycoproteins, that led to the early identification of these molecules as the major transplantation antigens. It is usually assumed that the polymorphism is advantageous for the species, as it may ensure that at least some MHC allelic form will efficiently bind and present an antigen. However, it is difficult to explain how this polymorphism would be selected for, as in most cases there would be no apparent selective advantage for an individual carrying a new mutant form of the MHC molecule. An interesting alternative hypothesis was recently put forward, suggesting that the polymorphism might help to recognize quickly viruses coming from another individual of the species and carrying the MHC glycoproteins as captured components of the host cell membrane (Andersson et al., 1987) .
MHC glycoproteins may possibly have yet other functions in addition to serving as receptors (or rather carriers) for processed antigens: some anti-MHC class II mAbs can stimulate monocytes (Palacios, 1985) or B lymphocytes (Cambier et al., 1987b) suggesting that interaction with a natural ligand (e.g. CD4?) may deliver a positive signal to the antigen-presenting cell; interestingly, one of the proteins apparently associated intracellularly with MHC class II glycoproteins in activated B cells is the regulatory subunit of cyclic AMPdependent protein kinase (Newell et al., 1986) .
Some mAbs directed against MHC class I glycoprotein inhibit T and B lymphocyte functions (De Felice et al., 1987; Taylor et al., 1987) , which may indicate an additional functional role for these molecules. Anti-MHC class I mAbs stimulate monocytes to production of a suppressive soluble factor (Dasgupta & Yunis, 1987) . It can be speculated that these effects reflect functional association of MHC class I glycoproteins with some leucocyte surface receptors. It has been indeed shown that they are associated with receptors for insulin (Due et al., 1986) , epidermal growth factor (Schreiber et al., 1984) and glucagon (Lafuse & Edidin, 1980) . MHC class I glycoproteins may be involved in an as yet unclear carbohydrate-dependent way in the regulation of intercellular interactions (Lengerova et al., 1977; Pimlott & Miller, 1986) .
Finally, 'nonclassical' MHC class I molecules exist, the function of which is quite unknown (Paul et al., 1987; Srivastava et al., 1987) . There are many genes in the major histocompatibility complex of man and mouse potentially coding for these molecules but so far little is known about their products (Lew et al., 1986) .
Structurally closely related to MHC class I glycoproteins are the CD1 molecules (van de Rijn et al., 1983) . They also consist of 43-48 kDa heavy chains noncovalently associated with fl2-microglobulin. At least three types (CD 1 a, b, c) are expressed on different cells (Table 1) . CD1a on the surface of thymocytes is 19i8 covalently linked to CD8 (Snow et al., 1985a,b) . The CDl gene complex is not linked to the MHC locus (Calabi & Milstein, 1986) . The functions of CD1 are totally unknown.
It can be concluded that surprisingly much remains unknown about many aspects of the mechanisms used by lymphocytes for specific recognition of foreign antigens. Adhesion molecules Adhesion of various types of leucocytes to other cells is essential for many of their functions. Close cell-cell contact is, e.g., required during the attack of target cells by the Tc, during co-operation of Th with antigenpresenting cells, during 'homing' of lymphocytes into lymph nodes and other organs, during phagocytosis, during differentiation of T cells in thymus etc. Some of the molecules mediating these intercellular interactions have now been identified and studied in detail. Actually, the T cell receptor complex, MHC glycoproteins, CD4 and CD8 discussed in the preceding paragraph also participate fundamentally in antigen-specific cell-cell contacts. Other, antigen-'non-specific' systems are discussed below.
(1) Fibronectin receptors and related molecules that mediate the interactions of leucocytes (but also of other types of cells) with extraceliular matrix. These cell adhesion molecules of broad expression, called also 'integrins', have been recently reviewed (Hynes, 1987; and need not be discussed in detail here. It should be only noted that these receptors share sequential similarities and recognize the Arg-Gly-Asp sequence in fibronectin (Pytela et al., 1986) . Among this family of receptors expressed on leucocytes belong at least some of the VLA ('very late activation') antigens (Hemler et al., 1987a; see Table 5 ) and the gpllb/IIIa (CDw41) ( Table 5 ). The VLA antigens (VLA-1 through VLA-5) share a common 135 kDa ,-subunit noncovalently associated with different a-subunits (135-220 kDa) (Hemler et al., 1987a) . At least the VLA-3 and VLA-5 molecules are fibronectin receptors .
(2) The CD2-LFA-3 system is used during interactions of T cells with their targets Takai et al., 1987) . CD2 is expressed on all T cells, while its partner, LFA-3, is broadly expressed on various cell types. Both CD2 (Table 1) and LFA-3 (Table 5) are strongly glycosylated, and, interestingly, have significant sequence similarities to each other indicating common evolutionary origin; both these molecules have certain sequence similarities to the immunoglobulin family. CD2 has an unusually large intracytoplasmic C-terminal domain suggesting a potential for interactions with cytoskeleton or other intracellular components (Sewell et al., 1987) . Two alternative forms of LFA-3 exist, one of them being a typical membrane-spanning protein, while the other is anchored in the membrane via a covalently linked phosphatidylinositol moiety Wallner et al., 1987) . So far nothing is known about functional differences between these two forms of LFA-3. There are reports on carbohydrate-binding activity of CD2 (Semenyuk & Brain, 1985) but it is not clear whether CD2 recognizes a carbohydrate structure in LFA-3. It is possible that CD2 can bind yet another so far unknown ligand in addition to LFA-3; this is indirectly suggested by the fact that after T cell activation, a novel epitope appears on CD2 (called Tl13), arising probably by a poorly understood conformational change (Meuer et al., 1984; Peterson & Seed, 1987) . mAbs against this epitope stimulate T cells in vitro, when simultaneously LFA-3 or mAbs against other CD2 epitopes are present (Hunig et al., 1987; Olive et al., 1986) . Thus, it can be speculated that in vivo an unidentified lymphokine or some cell-bound ligand can bind to CD2 after it has bound LFA-3 on the target cell. The ability of some anti-CD2 mAb pairs and of LFA-3 plus anti-CD2 mAb to stimulate T cells, as well as the structure of the CD2 molecule, suggest that it is not only a ' passive' adhesion molecule, but that activation signals can be delivered through it. Activation through CD2 is functionally linked to the T cell receptor-mediated activation (reviewed by Alcover et al., 1987) , 1987) . Similarly, LFA-3 may not be only a passive adhesion molecule, since its cross-linking on the surface of antigen-presenting cells stimulates them to interleukin-1 production (Le et al., 1987) .
(3) The LFA-1-based adhesion system (reviewed by Martz, 1987) appears to be critically important for adhesion of T, to their targets (Krensky et al., 1983; Shaw et al., 1986a) and probably also in other leucocyte interactions. The LFA-1 molecule (Table 5) is broadly expressed on leucocytes; it consists of two glycoprotein transmembrane subunits: a (CD lla) and , (CD1 8) (170 kDa and 95 kDa, respectively). The , subunit is sequentially similar to fibronectin receptors (Kishimoto et al., 1987; Law et al., 1987) and can be associated with two other a subunits called now CD1lb and CD1lc (Krensky et al., 1983; see Table 4 ). During the cell-cell contact LFA-1 probably binds to a so far poorly characterized molecule called ICAM-1 (Dustin et al., 1986) . Defective expression of CD18 (the , subunit) in some individuals causes severe dysfunctions of their immune system, obviously due to impaired leucocyte adhesivity .
(4) 'Homing' systems are used to target leucocytes to specific organs and tissues. The murine receptor responsible for homing of lymphocytes to lymph nodes is a 95 kDa glycoprotein with unusual branched structure due to covalent attachment of several ubiquitin chains (for review see Gallatin et al., 1986) and recognizes complex carbohydrates containing 6-phosphomannosyl residues (Yednock et al., 1987) . A very similar molecule seems to be involved also in homing of human lymphocytes to lymphoid organs (Jalkanen et al., 1986 (Jalkanen et al., , 1987 .
In conclusion, multiple systems of intercellular adhesion are used by leucocytes (Fig. 2) Multiple soluble mediators of polypeptide or glycoprotein nature are essential in regulation of leucocyte growth differentiation and proliferation. All these soluble factors act through specific receptors expressed on the surface of target cells. In many cases these receptors are present only in very small amounts, which has so far prevented their isolation and thorough biochemical characterization. Here we will only briefly mention several well characterized receptors of this kind. Several others, for which less information is available, can be found in Tables 2, 4 and 5.
The receptor for interleukin-2 is by far the most thoroughly studied lymphokine receptor. The highaffinity receptor consists of noncovalently associated subunits a (55 kDa, called also Tac or CD25) and , (75 kDa), both of which have a medium affinity for interleukin-2 themselves (Sharon et al., 1986; Smith, 1987) . Both subunits can exist independently on the cell surface. The free fi subunit is present on the surface of, e.g., resting T cells or NK cells (Bich-Thuy et al., 1987; Siegel et al., 1987) and serves as the functional IL-2 receptor. After T cell activation, the a chain (CD25) is rapidly expressed and after its association with the fi chain an apparently more efficient receptor is formed (Wang & Smith, 1987) .
Interaction of interleukin-2 with isolated a chain seems to deliver a negative signal to the cell . Crosslinking experiments revealed recently the presence of a third, 95-100 kDa, subunit associated with the interleukin-2 receptor (Szollosi et al., 1987; Saragovi & Malek, 1987) . The structure of the a subunit is known in great detail (reviewed by Waldmann, 1986, and , while little is known about the ,8 subunit and the 95-100 kDa ' subunit. The mechanism of signal transduction t?rough the interleukin-2 receptor is unclear; apparently the , subunit (75 kDa) is phosphorylated by a receptor-associated protein kinase after interleukin-2 binding (Benedict et al., 1987) ; it is possible that the subunit itselfis the protein kinase. Internalization of interleukin-2 is mediated by the , subunit but not the a subunit Vol. 253 high concentrations were observed in the sera of patients with leukaemia (Semenzato et al., 1987) .
The interleukin-2 receptor appears to be an interesting multicomponent complex, the elucidation of whose functions will become possible only after thorough structural description of its components.
Another well characterized receptor is that for a haemopoietic growth factor called CSF-1 (colony stimulating factor 1, also called M-CSF), expressed mainly on human macrophages (Table 4 ). This typical integral membrane glycoprotein of 165 kDa has a large cytoplasmic domain with ligand-dependent tyrosinekinase activity (Coussens et al., 1986) . A form of the feline receptor modified in the C-terminal domain was shown to be identical to the product of the v-fms oncogene. This truncated receptor phosphorylates itself constitutively, which results in deregulated cell proliferation (Sherr et al., 1985; Wheeler et al., 1986) .
Basic biochemical properties of human receptors for interleukin-6 (Coulie et al., 1987, see Table 2 ) and for socalled GM-CSF (Park et al., 1986; see Table 4 ) have been determined, while only murine receptors for interleukin-3 and GM-CSF have been studied so far (for review of the CSF receptors see Nicola, 1987) . Some basic information is also available on the nature of the murine receptor for interleukin-4 (Park et al., 1987) , which may be associated with the LFA-1 molecule (Mishra et al., 1986) .
Recent data on interferon y receptor have been reviewed (Rubinstein et al., 1987) ; little is known about the biochemical character of this important receptor except that molecules of 90 kDa and 50 kDa have the receptor activity (Auget & Merlin, 1987) .
Little is also known about the receptor for an important multifunctional cytokine, interleukin-1. The cell-surface receptor is a 60 kDa molecule as determined by affinity-crosslinking experiments (Matsushima et al., 1986 ; see also review by Dower & Urdal, 1987 ). An immunosuppressive urinary glycoprotein called uromodulin appeared to be a soluble form ofan interleukin-I receptor (Muchmore & Decker, 1986) ; apparently, interleukin-1 binds in a lectin-like fashion to the carbohydrate moiety of this glycoprotein. Recently uromodulin was identified as the major urinary TammHorsfall glycoprotein . Interleukin-1 seems to have two separate binding sites through which it interacts with this soluble glycoprotein and with the cellular receptor, respectively . The physiological meaning of the interaction with the urinary glycoprotein is unknown.
The antigen CD23 (discussed in more detail in the following paragraph on Fc receptors) was reported to be the receptor for so-called 'low-molecular-weight B cell growth factor' .
Identification and thorough elucidation of structure and function of cytokine receptors on leucocytes will certainly become one of the central topics of leucocyte membranology, as it should bring an understanding of the principles governing the regulation of leucocyte growth and differentiation and of their defects in malignant transformation, with potentially important practical medical implications.
Transferrin and insulin can be considered as growth factors of proliferating leucocytes (and of other cells as well). Transferrin receptor is a typical 'activation antigen' expressed on a variety ofdividing cells including activated lymphocytes and early thymocytes. Its structure and function have been reviewed in detail (Testa, 1985; Huebers & Finch, 1987) . This covalent homodimer of a 90 kDa subunit is unusual in that the polypeptide is oriented with N-terminus intracellularly (Schneider et al., 1984; McClelland et al., 1984) . An open question is whether transferrin receptor on tumour cells serves as the target molecule recognized by NK cells (Vodinelich et al., 1983; Dokhelar et al., 1984) . Also, it is not quite clear whether the interaction of transferrin with the receptor does provide a growth-stimulatory signal independent of the iron-delivery function .
Structure and function of the insulin receptor (Table 5 ) have been recently thoroughly reviewed elsewhere (Van Obberghen & Gammeltoft, 1986) .
Receptors for immunoglobulins
Several types of receptors for the Fc portion of immunoglobulin molecules exist on different subpopulations of human leucocytes. Recently great progress is being made toward detailed molecular characterization of these receptors. Among the relatively well characterized human leucocyte Fc receptors are CD 16, CDw32 and the monocyte high-affinity Fc receptor (all receptors Sinclair & Panoskaltsis, 1987) . B lymphocyte Fc receptor was reported to have a phospholipase A2 activity (Suzuki et al., 1981) , which is a key enzyme in the prostaglandin synthesis. The regulatory effects of this Fc receptor on immunoglobulin production could then be due to affecting the synthesis of prostaglandins, substances with strong immunomodulatory effects. Most is known about the mechanism of action of the basophil/mastocyte high affinity receptor for IgE which mediates the familar allergic reactions. Its structure and function have been reviewed extensively recently (Metzger et al., 1986) . The a subunit of this multichain complex (Table 4) binds the Fc part of monomeric IgE and after interaction with the corresponding antigen the resulting crosslinking of receptors leads to rapid 'degranulation' ofthe mastocytes or basophils, which causes a strong local tissue reaction.
The amino acid sequence of the a subunit of the rat receptor predicted from the structure of cDNA has significant similarities to murine Fc receptor Lyl7 (Kinet et al., 1987) .
Another IgE receptor is the CD23 antigen which is weakly expressed on resting lymphocytes and strongly on activated B cells (Table 2 ). In addition to a relatively low-affinity binding of IgE it-was, reported-to be also the receptor for 'low-molecular-weight B cell growth factor' , a so far rather poorly defined lymphokine. The CD23 molecule has several other Vol: 253 interesting features: it has a significant sequential similarity to the hepatic receptors for asialoglycoproteins, which might indicate that CD23 also is a lectin (Kikutani et al., 1986; Ikuta et al., 1987) . Further, it is unusually oriented in the membrane, with the C-terminus being extracellular, similar to, e.g., the transferrin receptor. Most interestingly, a soluble fragment of the CD23 molecule produced probably by proteolytic cleavage appears to be an autocrine growth factor for B cells (Swendeman & Thorley-Lawson, 1987) ; it is not known what is the mechanism underlying this phenomenon, e.g. what is the receptor for this fragment. Thus, CD23 seems to be an extremely interesting receptor with perhaps too many functions identified; it may be a molecule of key importance for B cell growth regulation (Guy & Gorden, 1987) and IgE may well prove to be an important B cell cycle regulatory molecule in addition to its known effector functions.
Existence of soluble forms of Fc receptors may be a more general phenomenon of uncertain physiological importance; in addition to soluble CD23 also CDw32 is easily shed as a soluble fragment (Looney et al., 1986 
Complement receptors and related molecules
This is a group of often structurally related membrane receptors capable of recognizing different complement components and their fragments. As these receptors were reviewed elsewhere (Fearon, 1984; Gresham & Volanakis, 1986) we will only very briefly point out some interesting or most recently described features. Basic data on these molecules can be found in Table 2 [complement receptor type 2 (CD21)], Table 4 [complement receptor type 3 (CDl lb/CD18), CDl lc/CD18 and C5a receptor] and Table 5 [complement receptor type 1 (CD35), decay accelerating factor, Clq receptor, GP45-70 (MCP) and HRF]. These receptors serve apparently several different functions: first, they help to recognize by phagocytic cells the pathogens 'opsonized' with complement fragments (complement receptor type 3); interaction of the C3d fragment with CD21 (complement receptor type 2) seems to be an important signal regulating the lymphocyte cell cycle (Melchers et al., 1985) and moreover, CD21 is the receptor for EpsteinBarr virus (Fingeroth et al., 1984) . The C5a receptor is important for chemotaxis of monocytes and granulocytes toward the inflammation sites.
A group of these receptors have regulatory functions (decay accelerating factor, MCP and HRF) as they prevent spontaneous deposition of activated complement fragments on the self-cells . The complement receptors CD35, CD21 and decay accelerating factor display significant sequence similarities and the genes for these homologous proteins form a cluster on human chromosome 1 ]. Further, this receptor has a lectinlike carbohydrate-binding activity which may be important for recognition of some microbial cell wall carbohydrates . Complement receptor type 3 also appears to be a cell adhesion molecule (Dana et al., 1986) , as does the other member of the CDi 1 family with complement receptor activity, p150,95 (CDl lc/CD18) (Keizer et al., 1987a) . CD35 (complement receptor type 1) is predicted to be an unusual rod-like molecule consisting of 30 short consensus repeats of 60 amino acid residues . Interestingly, allelic forms exist which considerably differ in the number of these basic structural units but still normally bind C3b and C4b (Dykman et al., 1985) .
Decay accelerating factor belongs to the receptors anchored in membrane by the phosphatidylinositol moiety . Multiple forms of decay accelerating factor exist (Seya et al., 1987) , including a soluble one produced by unusual mRNA splicing involving a frame-shift in the C-terminal region (Caras et al., 1987) , but nothing is known about the roles of these alternative forms.
Activation antigens
Activation of leucocytes by various stimuli normally leads to expression of new surface components or greatly increased expression of molecules already present on the resting cells. Many of these molecules have been already discussed in previous paragraphs. The kinetics of expression is very different for different antigens (hours for early activation antigens, days or even weeks for late or very late activation antigens).
Among the activation antigens belong typically CD25 (low-affinity interleukin-2 receptor), transferrin receptor, CD23 and the Blast-I antigen (Table 2) . Another characteristic activation antigen of many cell types is the 4F2 molecule (Haynes et al., 1981) , which appears to be a Na+/Ca2" exchanger (Bron et al., 1986 ) of interesting two-chain structure (Table 5 ). Some of these molecules, such as transferrin receptor or 4F2, may be recognized by NK cells as markers of rapidly growing tumour cells (Vodinelich et al., 1983; Moingeon et al., 1985) .
Other activation antigens of so far unknown function are, e.g., CD30 (Table 5) or the 18 kDa antigen of Vol. 253 Remold-O'Donnell et al., (1984 , , Axelson et at. (1985), Mentzer et al. (1987 , Reisinger & Parkman (1987) , Borche et al. (1987 ) Sportsman et al. (1985 , 
Vol. 253 Also the 'very late activation antigens' (VLA) which appear after 2-3 weeks of culture on activated T cells and are apparently related to the fibronectin receptors , have been shortly discussed in the paragraph on adhesion molecules. Their molecular mass, subunit composition and expression suggest that the molecules called CDw26 (Haynes, 1986) and LDA1 (Suciu-Foca et al. 1985) (Table 1) ; CDl9, CD20, CD22, CDw4O, AB-1 (Table 2) ; Ea3, L24, L25 (Table 5) . Obviously, finding physiological ligands for these molecules would be of major importance.
Among other functionally important molecules are, e.g., CD43 and CD45 (Table 5 ). CD43 is the major leucocyte sialoglycoprotein described also under the names leukosialin or sialophorin Mentzer et al., 1987; Borche et al., 1987) . There is one report on mitogenic activity of a mAb against this antigen (Mentzer et al., 1987) ; moreover, the expression of this sialoglycoprotein is defective in patients affected by Wiskott-Aldrich syndrome (Remold-O'Donnell et al., 1984) . It is possible that sialic acid residues carried by this antigen protect the cells from premature removal from circulation through the asialoglycoprotein receptors in liver (Reisinger & Parkman, 1987) . Moreover, similarity in molecular size might indicate a relation of CD43 (or of a similar sialoglycoprotein CDw44) to the homing receptor (Jalkanen et al., 1986) .
Numerous mAbs against the 'leucocyte common antigen' CD45 (Table 5 ) enhance stimulation of T cells (Martorell et al., 1987) , inhibit activation of B cells (Mittler et al., 1987) and block cytotoxic activity of NK cells . In addition, expression of alternative forms of CD45 correlates with functions of T lymphocyte subsets (see the following paragraph). The CD45 molecules have a large intracellular domain (Ralph et al., 1987) interacting specifically with cytoskeleton (Bourguignon et al., 1985) . All these observations strongly suggest a functional importance of these molecules, but the natural ligand is still to be found.
Yet another functionally important but so far incompletely understood molecule is CD9 (Table 5 ). This antigen, attached to the cell membrane via a lipid anchor (LeBien et al., 1985) , is structurally closely related to the platelet derived growth factor (PDGF) and to the product of sis oncogen (Wood et al., 1986 ), it has a protein kinase activity (Zipf et al., 1986 ) and the isolated antigen has a growth-promoting activity (Zeleznik et al., 1987) . It may be speculated that CD9 could be a membrane-bound PDGF just as both soluble and membrane-bound interleukin-1 exist (Weaver & Unanue, 1986) . Molecules whose expression defines functional leucocyte subpopulations As discussed to some extent in the previous paragraphs, the expression of some surface antigens is more or less restricted to certain leucocyte types and subpopulations. Detection of such molecules with restricted expression is invaluable for identification of the respective cell subsets. Thus, mlg and T cell receptor complex are characteristic markers (and most important functional molecules) of B and T lymphocytes, respectively. In addition there are a few other absolutely T cell-specific (CD7, CD27) or B cell-specific (e.g. CD19, CD20) antigens and CD14 and CDI 5 are reliable markers of monocytes and granulocytes, respectively. In most cases, the expression of other leucocyte surface antigens is not absolutely cell-type specific, but there are, e.g., molecules expressed on T cells and plasma cells (CD28), on T cells and a subpopulation of B cells (CD5), T cells and monocytes (CD4), etc. (see Tables 1-5 ). However, there are a few molecules that define, mostly in combination with other markers, a smaller functional subset of lymphocytes-. Thus, T cell receptor the y& type is expressed on a subpopulation of T lymphocytes with 'NK-like' activity which seems to be a lineage of T cells completely different from the major subpopulation carrying the c4?-type T cell receptor (Allison & Lanier, 1987) . The nearly mutually exclusive expression of CD4 and CD8 molecules on T lymphocytes defines two subsets: the CD4 pool consists mostly of (1) Th secreting lymphokines enhancing differentiation and proliferation of B lymphocytes and (2) so-called inducers of suppressor cells (i.e. cells helping in development of TJ); the CD8+ subpopulation of T cells is responsible for most of the MHC-restricted cellmediated cytotoxicity (T,) and for suppressive activity (Ts).
The two subsets of CD4+ T cells can be phenotypically distinguished by expression of molecules called CDw29 (Table 1) and UCHL-l (a 160 kDa form of the CD45 antigen) on the 'true' Th, and CD45R (205 kDa and 220 kDa forms of the CD45 antigen) on the suppressorinducer subset (Morimoto et al., 1986a; Beverley, 1987) It is not quite clear what are the surface molecules reliably distinguishing T, from Ts; it was reported that the cells expressing both CD8 and CD28 are T, while the cells expressing CD8 and CD 11 /CD1 8 (previously called Mo 1), but not CD28 are T. (Yamada et al., 1985) . Also, the expression of a so far poorly biochemically characterized antigen Leu8 (Table 1) may differentiate between Tc and Ts and even between different subsets of T. (Kansas & Engelman, 1987 Beverley (1987) . There are several antigens more or less specifically expressed on NK cells (Table 3) . Interestingly, there are apparently NK-specific forms of CD45 which again stresses the functional importance of this family of molecules. It should be noted that there is some confusion concerning the definition of 'true' NK cells, which should be the non-T, non-B cells expressing the markers given in Table 3 and also the CD 1 a/CD 18 and CD16 molecules .
Another useful marker is the CD5 antigen (Table 1) which is expressed on all T lymphocytes but also on a minor functionally important subpopulation of B lymphocytes which produce IgM autoantibodies against immunoglobulin and other self-antigens (Casali et al., 1987) .
The Tal antigen (Table I) appears to be a marker of memory T cells, i.e. the T cells that had been previously activated by specific antigen (Hafler et al., 1986) . Unfortunately, so far no surface molecule specific for memory B cells has been found; discovery of such a marker would be of major importance for better understanding of the nature of this very important but so far rather elusive subset.
Plasma cells, i.e. the terminal differentiation stage of B lymphocytes, are characterized by their expression of PC-1 and PCA-1 molecules (Table 2 ); in addition these cells express also the T cell molecules CD28 (Kozbor et al., 1987) and CD38 .
The recently described antigen HML-1 (Table 5 ) identifies an interesting subset of intestinal lymphocytes (Cerf-Benussan et al., 1987) .
From a practical point of view, it would be extremely useful to have markers specific for various malignant leucocytes. Such markers do exist, e.g. the expression of CD9 and CD I0 is of diagnostic value for identification of acute lymphoblastoid leukaemia, the TALLA and cCLLa molecules (Tables 1 and 2 , resp.) appear to be markers of T-cell acute lymphoblastoid leukaemia and chronic lymphoblastoid leukaemia, respectively, CD14, CD33 and CD34 are useful markers of myeloid leukemias (Foon & Todd, 1986) . However, all these molecules are also present on some normal leucocytes, e.g. some bone marrow cells; CD10 is strongly expressed on kidney parenchymal cells and normal granulocytes (Metzgar et al., 1981) . Expression of these leukaemia-associated antigens on normal cells prevents, to large extent, e.g. the use of specific mAbs for therapeutic purposes. Types of association with membrane and soluble forms of leucocyte surface antigens
The great majority of leucocyte surface glycoproteins are integral membrane proteins associated with the lipid membrane via a hydrophobic stretch of amino acid residues located usually in the C-terminal part of the polypeptide; in most cases the C-terminal domain is intracellular, but the orientation of several leucocyte antigens is reversed, with C-terminal part being extracellular. Among these 'upside-down' antigens (sometimes called 'type II membrane proteins') are transferrin receptor, CD23 and heavy chain of the 4F2 activation antigen.
The second type of association with membrane is via a phospholipid (phosphatidylinositol) moiety covalently bound usually to a hydrophobic region in the C-terminal part of the polypeptide chain (see the review by Low, 1987 In many cases soluble forms of otherwise membraneassociated leucocyte molecules occur. Sometimes, these are translation products of alternatively spliced mRNA from which the membrane-spanning segment is absent. The best known example is immunoglobulins, and a similar situation was described for decay accelerating factor (Caras et al., 1987) . It seems likely that soluble Fc receptors ('immunoglobulin binding factors') are similarly related to the membrane-bound Fc receptors (MacLean et al., 1984) .
In other cases the soluble forms arise by proteolytic cleavage of the originally membrane-bound molecule which is in agreement with the usually observed smaller size of the soluble forms. This is probably the case for CD25 (Rubin et al., 1986) , CD8 (Fujimoto et al., 1984) , CD28 (Gmunder & Lesslauer, 1984) , CD23 (ThorleyLawson et al., 1986) , CD21 (Myones & Ross, 1987) , CDw32 (Looney et al., 1986; Vaughn et al., 1985) and CD35 (Yoon & Fearon, 1985) . It is not clear what is the relation between the soluble and membrane-bound forms of CD 14, as both appear to be of identical size (Bazil et al., 1986) .
Conceivably, soluble forms of phosphatidylinositolanchored molecules can be produced by enzymic cleavage of the lipid moiety; soluble CD10 might be perhaps produced in this way (Komada et al., 1986) .
It is not clear what are the physiological roles of the soluble forms. Soluble forms of CD9 (Zeleznik et al., 1987) and CD23 (Swedeman & Thorley-Lawson, 1987) were reported to have growth-factor activities, and soluble CD25 may regulate the level of interleukin-2 (Rubin et al., 1986) . The serum level of soluble CD14 is higher in some patients, especially those with some autoimmune diseases (Bazil et al., 1986) , but the relevance of this finding is so far unclear. (De Santis et al., 1987) .
